BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33214024)

  • 1. Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old: A French prospective cohort.
    de Moreuil C; Le Mao R; Le Moigne E; Pan-Petesch B; Tromeur C; Hoffmann C; Salaun PY; Nonent M; Danguy des Déserts M; Savary X; Guegan M; Poulhazan E; Leroyer C; Lacut K; Couturaud F
    Eur J Intern Med; 2021 Feb; 84():24-31. PubMed ID: 33214024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
    J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort.
    Rodger MA; Scarvelis D; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Gandara E; Solymoss S; Sabri E; Kovacs J; Kovacs MJ
    Thromb Res; 2016 Jul; 143():152-8. PubMed ID: 27086275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
    Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
    Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
    Aziz D; Skeith L; Rodger MA; Sabri E; Righini M; Kovacs MJ; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther MA; White RH; Le Gal G
    J Thromb Haemost; 2021 Jun; 19(6):1526-1532. PubMed ID: 33724705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cosmi B; Cushman M; Kyrle P; Poli D; Tait RC; Iorio A
    BMJ; 2011 Feb; 342():d813. PubMed ID: 21349898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE.
    Giustozzi M; Valerio L; Agnelli G; Becattini C; Fronk EM; Klok FA; Konstantinides SV; Vedovati MC; Cohen AT; Barco S
    Eur J Intern Med; 2021 Jun; 88():43-51. PubMed ID: 33810940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.
    Rodger MA; Le Gal G; Anderson DR; Schmidt J; Pernod G; Kahn SR; Righini M; Mismetti P; Kearon C; Meyer G; Elias A; Ramsay T; Ortel TL; Huisman MV; Kovacs MJ;
    BMJ; 2017 Mar; 356():j1065. PubMed ID: 28314711
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.
    Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K
    Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
    Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
    Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
    Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
    Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
    J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.